Cite
APA Citation
Cid, M. C., Unizony, S. H., Blockmans, D., Brouwer, E., Dagna, L., Dasgupta, B., Hellmich, B., Molloy, E., Salvarani, C., Trapnell, B. C., Warrington, K. J., Wicks, I., Samant, M., Zhou, T., Pupim, L., & Paolini, J. F. (2022). efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. Annals of the rheumatic diseases, 81(5), 653–661. http://access.bl.uk/ark:/81055/vdc_100153429951.0x000038